Recruiting

NCT Number: NCT05645510

LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study

People with advanced chronic cancers are now living for many years as a result of new targeted anti-cancer treatments. Many of these treatments are quite new and people may take them for months, even years, as long as the treatments are helping. The purpose of this study is to help understand how to best support people receiving these treatments.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Cancer Adnexal Diseases Blood Protein Disorders Breast Cancer Breast Diseases Breast Neoplasms Cardiovascular Diseases Chronic Leukemia Colonic Diseases Colorectal Cancer Colorectal Neoplasms Digestive System Diseases Digestive System Neoplasms Endocrine Gland Neoplasms Endocrine System Diseases Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Gastrointestinal Diseases Gastrointestinal Neoplasms Genital Diseases Genital Diseases, Female Genital Diseases, Male Genital Neoplasms, Female Genital Neoplasms, Male Gonadal Disorders Hematologic Diseases Hemic and Lymphatic Diseases Hemorrhagic Disorders Hemostatic Disorders Immune System Diseases Immunoproliferative Disorders Intestinal Diseases Intestinal Neoplasms Lung Cancer Lung Diseases Lung Neoplasms Lymphoproliferative Disorders Male Urogenital Diseases Melanoma Multiple Myeloma Neoplasms Neoplasms by Histologic Type Neoplasms by Site Neoplasms, Germ Cell and Embryonal Neoplasms, Nerve Tissue Neoplasms, Plasma Cell Neuroectodermal Tumors Neuroendocrine Tumors Nevi and Melanomas Ovarian Cancer Ovarian Diseases Ovarian Neoplasms Paraproteinemias Prostate Cancer Prostatic Diseases Prostatic Neoplasms Rectal Diseases Respiratory Tract Diseases Respiratory Tract Neoplasms Skin Diseases Skin Neoplasms Skin and Connective Tissue Diseases Thoracic Neoplasms Tyrosine Kinase Mutation Urogenital Diseases Urogenital Neoplasms Vascular Diseases

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Edith Pituskin

Edmonton, Alberta, T6G 1C9, Canada

Location status: Recruiting

Location contact

Edith Pituskin, PhD

CONTACT

[email protected]

7804328221

About this study

Participants ill be scheduled for an in-person, telephone or computer video interview with the researcher(s). They will be asked about their experiences receiving targeted anti-cancer treatments. Then over the next 3 months, participants will be asked to think about how receiving these cancer treatments affects daily living and to create a 'metaphor'. Metaphors may be composed with any mix of visual, verbal, musical or other works participants feel expresses and brings their experiences to life.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

taking chronic targeted anti-cancer agents -

Exclusion criteria

Treatment and study plan

Primary outcomes

Interview

Time frame: 3 months

Interview to learn the experiences of people living with incurable cancers

Study contacts

Contact information is provided by the study sponsor or research team.

Edith Pituskin, PhD

CONTACT

[email protected]

7804328221

Meredith Porter Hogg, MN

CONTACT

[email protected]

Sponsors and collaborators

Lead sponsor

University of Alberta

Other

Collaborators

Social Sciences and Humanities Research Council of Canada

Registry information

Acronym: LONGEVITI

Important dates

Study start: 2022
Primary completion: 2026
Study completion: 2026
First posted: Dec 9, 2022
Registry last updated: May 11, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting